Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

OS07.1.A A threshold of mitotic activity and post-surgery residual volume are independant prognostic factors in astrocytoma IDH-mutant

Autor: S Tran, A Thomas, M Touat, C Karachi, F Lozano, K Mokhtari, C Dehais, L Feuvret, C Carpentier, M Giry, H Doukani, J Lerond, Y Marie, M Sanson, A Idbaih, A Carpentier, K Hoang-Xuan, L Capelle, F Bielle

Publikováno v: Neuro-Oncology. 24:ii15-ii15

Background The distinction between grade 2 and 3 is instrumental to choose between observational follow-up and adjuvant treatment in resected astrocytoma IDH-mutant. However, criteria of grade 2 versus 3 have not been updated since the WHO 2007 class

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42b625332f782626dd56b71169ddb38e
https://doi.org/10.1093/neuonc/noac174.046

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial

Autor: Marie-Laure Welter, Jean-Luc Houeto, Stéphane Thobois, Benoit Bataille, Marc Guenot, Yulia Worbe, Andreas Hartmann, Virginie Czernecki, Eric Bardinet, Jerome Yelnik, Sophie Tezenas du Montcel, Yves Agid, Marie Vidailhet, Philippe Cornu, Audrey Tanguy, Solène Ansquer, Nematollah Jaafari, Emmanuel Poulet, Giulia Serra, Pierre Burbaud, Emmanuel Cuny, Bruno Aouizerate, Pierre Pollak, Stephan Chabardes, Mircea Polosan, Michel Borg, Denys Fontaine, Bruno Giordana, Sylvie Raoul, Tiphaine Rouaud, Anne Sauvaget, Isabelle Jalenques, Carine Karachi, Luc Mallet, M.L. Welter, E. Cuny, P. Derkinderen, D. Fontaine, J.L. Houeto, I. Jalenques, L. Mallet, P. Pollak, S. Thobois, A. Bissery, H. Oya, E. Bardinet, J. Yelnik, A. Buot, V. Czernecki, S. Tezenas du Montcel, A. Tanguy, M. Hajji, C. Karachi, A. Hartmann, Y. Agid, Y. Worbe, D. Dormont, M. Vidailhet, P. Cornu, B. Aouizerate, P. Burbaud, F. Durif, C. Fauchon, F. Rondepierre, P. Derost, M. Aya Kombo, M. Polosan, S. Chabardès, A. Krainik, P. Krack, B. Piallat, M. Guenot, E. Poulet, H. Klinger, G. Serra, E. Broussolle, T. Rouaud, A. Sauvaget, P. Damier, S Raoul, M. Borg, B. Giordana, M.-N. Magnie-Mauro, N. Jaafari, B. Bataille, S. Ansquer, I. Benatru, A. Fradet, E. Dugast, A. Ouerdani, E. Rabois, M. Quintin, S. Palfi

Publikováno v: The Lancet Neurology, Vol. 16, No 8 (2017) pp. 610-619
The Lancet Neurology
The Lancet Neurology, Elsevier, 2017, 16 (8), pp.610-619. ⟨10.1016/S1474-4422(17)30160-6⟩
Lancet Neurology
Lancet Neurology, Elsevier, 2017, 16 (8), pp.610-619. ⟨10.1016/S1474-4422(17)30160-6⟩
The Lancet Neurology, 2017, 16 (8), pp.610-619. ⟨10.1016/S1474-4422(17)30160-6⟩

Summary Background Deep brain stimulation (DBS) has been proposed to treat patients with severe Tourette's syndrome, and open-label trials and two small double-blind trials have tested DBS of the posterior and the anterior internal globus pallidus (a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1323359f5567b3f23a9fbfc3dfba8f79
https://doi.org/10.1016/s1474-4422(17)30160-6